duoplavin
sanofi winthrop industrie - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antitrombotiske midler - duoplavin er indiceret til sekundær forebyggelse af atherotrombotiske hændelser hos voksne patienter, der allerede tager både clopidogrel og acetylsalicylsyre (asa). duoplavin is a fixed-dose combination medicinal product for continuation of therapy in:non st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention (pci);st segment elevation acute myocardial infarction (stemi) in patients undergoing a stent placement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. for yderligere oplysninger henvises der til afsnit 5.
aggrenox 200+25 mg depotkapsler, hårde
orifarm a/s - acetylsalicylsyre, dipyridamol - depotkapsler, hårde - 200+25 mg
dipyridamol/acetylsalicylsyre "2care4" 200+25 mg kapsler med modificeret udløsning, hårde
2care4 aps - acetylsalicylsyre, dipyridamol - kapsler med modificeret udløsning, hårde - 200+25 mg
orisantin 200+25 mg kapsler med modificeret udløsning, hårde
orion corporation - acetylsalicylsyre, dipyridamol - kapsler med modificeret udløsning, hårde - 200+25 mg
treo 500+50 mg brusetabletter
viatris aps - acetylsalicylsyre, caffein - brusetabletter - 500+50 mg
treo citrus 500+50 mg brusetabletter
viatris aps - acetylsalicylsyre, caffein - brusetabletter - 500+50 mg
triplo 500+50 mg brusetabletter
orifarm generics a/s - acetylsalicylsyre, caffein - brusetabletter - 500+50 mg
triplo citrus 500+50 mg brusetabletter
orifarm generics a/s - acetylsalicylsyre, caffein - brusetabletter - 500+50 mg
triplo 500+50 mg tabletter
orifarm generics a/s - acetylsalicylsyre, caffein - tabletter - 500+50 mg
treo hindbær 500+50 mg brusetabletter
viatris aps - acetylsalicylsyre, caffein - brusetabletter - 500+50 mg